Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Active not recruiting × NIH × Clear all

Phase

Phase 2 173 Phase 1 82 Phase 3 54 Phase 1/2 32 Phase 2/3 8 Phase NA 7 Phase 4 3 Phase EARLY_PHASE1 1

Status

Completed 11 Terminated 7 Withdrawn 1 Recruiting 1 Active not recruiting 1

Sponsor Class

OTHER 95 INDUSTRY 5 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Serous Adenocarcinoma 1

Interventions

Specimen Handling 1 Biopsy 1 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04494113 2026-03-18

Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy

National Cancer Institute (NCI)

Phase EARLY_PHASE1 Active not recruiting

Endometrial Serous Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡